Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 18
2004 30
2005 21
2006 28
2007 33
2008 25
2009 30
2010 40
2011 54
2012 48
2013 49
2014 44
2015 61
2016 59
2017 70
2018 84
2019 77
2020 79
2021 43
Text availability
Article attribute
Article type
Publication date

Search Results

770 results
Results by year
Filters applied: . Clear all
Page 1
The Role of Hepatitis B Core-Related Antigen.
Inoue T, Tanaka Y. Inoue T, et al. Among authors: tanaka y. Genes (Basel). 2019 May 9;10(5):357. doi: 10.3390/genes10050357. Genes (Basel). 2019. PMID: 31075974 Free PMC article. Review.
Novel biomarkers for the management of chronic hepatitis B.
Inoue T, Tanaka Y. Inoue T, et al. Among authors: tanaka y. Clin Mol Hepatol. 2020 Jul;26(3):261-279. doi: 10.3350/cmh.2020.0032. Epub 2020 Jun 15. Clin Mol Hepatol. 2020. PMID: 32536045 Free PMC article. Review.
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization.
Iwamoto M, Saso W, Sugiyama R, Ishii K, Ohki M, Nagamori S, Suzuki R, Aizaki H, Ryo A, Yun JH, Park SY, Ohtani N, Muramatsu M, Iwami S, Tanaka Y, Sureau C, Wakita T, Watashi K. Iwamoto M, et al. Among authors: tanaka y. Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8487-8492. doi: 10.1073/pnas.1811064116. Epub 2019 Apr 5. Proc Natl Acad Sci U S A. 2019. PMID: 30952782 Free PMC article.
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.
Kusumoto S, Arcaini L, Hong X, Jin J, Kim WS, Kwong YL, Peters MG, Tanaka Y, Zelenetz AD, Kuriki H, Fingerle-Rowson G, Nielsen T, Ueda E, Piper-Lepoutre H, Sellam G, Tobinai K. Kusumoto S, et al. Among authors: tanaka y. Blood. 2019 Jan 10;133(2):137-146. doi: 10.1182/blood-2018-04-848044. Epub 2018 Oct 19. Blood. 2019. PMID: 30341058 Free PMC article. Clinical Trial.
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement.
Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH, Yu ML, Piratvisuth T, Chan HL; Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic. Wong GL, et al. Among authors: tanaka y. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):776-787. doi: 10.1016/S2468-1253(20)30190-4. Epub 2020 Jun 23. Lancet Gastroenterol Hepatol. 2020. PMID: 32585136 Free PMC article.
Brainstem Organoids From Human Pluripotent Stem Cells.
Eura N, Matsui TK, Luginbühl J, Matsubayashi M, Nanaura H, Shiota T, Kinugawa K, Iguchi N, Kiriyama T, Zheng C, Kouno T, Lan YJ, Kongpracha P, Wiriyasermkul P, Sakaguchi YM, Nagata R, Komeda T, Morikawa N, Kitayoshi F, Jong M, Kobashigawa S, Nakanishi M, Hasegawa M, Saito Y, Shiromizu T, Nishimura Y, Kasai T, Takeda M, Kobayashi H, Inagaki Y, Tanaka Y, Makinodan M, Kishimoto T, Kuniyasu H, Nagamori S, Muotri AR, Shin JW, Sugie K, Mori E. Eura N, et al. Among authors: tanaka y. Front Neurosci. 2020 Jun 26;14:538. doi: 10.3389/fnins.2020.00538. eCollection 2020. Front Neurosci. 2020. PMID: 32670003 Free PMC article.
Reply.
Matsuura K, Kurosaki M, Tanaka Y. Matsuura K, et al. Among authors: tanaka y. Gastroenterology. 2017 Nov;153(5):1449-1450. doi: 10.1053/j.gastro.2017.10.004. Gastroenterology. 2017. PMID: 29096822 No abstract available.
Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial.
Takehara T, Sakamoto N, Nishiguchi S, Ikeda F, Tatsumi T, Ueno Y, Yatsuhashi H, Takikawa Y, Kanda T, Sakamoto M, Tamori A, Mita E, Chayama K, Zhang G, De-Oertel S, Dvory-Sobol H, Matsuda T, Stamm LM, Brainard DM, Tanaka Y, Kurosaki M. Takehara T, et al. Among authors: tanaka y. J Gastroenterol. 2019 Jan;54(1):87-95. doi: 10.1007/s00535-018-1503-x. Epub 2018 Sep 10. J Gastroenterol. 2019. PMID: 30203225 Free PMC article. Clinical Trial.
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
Ji F, Yeo YH, Wei MT, Ogawa E, Enomoto M, Lee DH, Iio E, Lubel J, Wang W, Wei B, Ide T, Preda CM, Conti F, Minami T, Bielen R, Sezaki H, Barone M, Kolly P, Chu PS, Virlogeux V, Eurich D, Henry L, Bass MB, Kanai T, Dang S, Li Z, Dufour JF, Zoulim F, Andreone P, Cheung RC, Tanaka Y, Furusyo N, Toyoda H, Tamori A, Nguyen MH. Ji F, et al. Among authors: tanaka y. J Hepatol. 2019 Sep;71(3):473-485. doi: 10.1016/j.jhep.2019.04.017. Epub 2019 May 13. J Hepatol. 2019. PMID: 31096005
770 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page